Latest Clinical Insights in Leukemia, Lung Cancer, and Myeloma from NCODA
NCODA shared a post on LinkedIn:
“Coming Up This Week at NCODA
Tue, Aug 19 | 2 p.m. EST
Dr. John Renshaw (Texas Oncology) will share practical strategies for supporting veterans with CLL and approaches for safely and effectively integrating zanubrutinib into treatment plans.
Wed, Aug 20 | 2 p.m. and 5 p.m. EST
Jessica Freydman, PharmD, BCOP (Massachusetts General Hospital), will provide a pharmacist’s perspective on emerging AML trends, therapeutic advances, and evolving treatment approaches in our disease education series.
Thu, Aug 21 | 2 p.m. EST
The NCODA International Monthly Webinar will address oncology policy and legislative changes that could impact care delivery, best practices for optimizing taletrectinib in ROS1+ NSCLC, and new isatuximab trial findings with discussion on the potential role of an investigational on-body injector in multiple myeloma.
See all upcoming webinars.”
More posts featuring NCODA on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023